abagovomab 19
abciximab 20
abituzumab 19
abrilumab 11
actoxumab 7
adalimumab 13
aducanumab 7
afasevikumab 8
alacizumab_pegol 7
alemtuzumab 20
alirocumab 9
amatuximab 25
andecaliximab 15
anifrolumab 13
anrukinzumab 16
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 12
ascrinvacumab 4
atezolizumab 13
atinumab 10
avelumab 8
basiliximab 16
bavituximab 17
begelomab 12
benralizumab 17
bevacizumab_beta 15
bezlotoxumab 7
bimagrumab 9
bleselumab 9
blinatumomab 18
blosozumab 26
bococizumab 13
brazikumab 10
brentuximab_vedotin 15
briakinumab 14
brodalumab 5
brolucizumab 22
brontictuzumab 15
burosumab 13
cabiralizumab 18
camrelizumab 9
canakinumab 19
cantuzumab_ravtansin 30
carlumab 12
carotuximab 9
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 23
cetiximab 26
citatuzumab_bogatox 23
cixutumumab 13
clivatuzumab_tetraxetan 10
codrituzumab 20
conatumumab 6
concizumab 17
crenezumab 13
crizanlizumab 16
crotedumab 17
dacetuzumab 19
daclizumab 10
dalotuzumab 20
dapirolizumab_pegol 19
daratumumab 11
dectrekumab 8
demcizumab 18
denosumab 8
depatuxizumab 15
depatuxizumab_mafodotin 15
dezamizumab 11
dinutuximab 27
diridavumab 10
domagrozumab 12
drozitumab 5
duligotuzumab 11
durvalumab 4
dusigitumab 6
efalizumab 27
efungumab 17
eldelumab 6
elezanumab 9
elgemtumab 6
elotuzumab 9
emactuzumab 14
emapalumab 18
emibetuzumab 10
enavatuzumab 22
enfortumab_vedotin 9
enoblituzumab 14
enokizumab 16
enoticumab 11
ensituximab 16
eptinezumab 11
erenumab 9
etaracizumab 13
etrolizumab 21
evinacumab 16
evolocumab 3
farletuzumab 3
fasinumab 16
fezakinumab 7
fibatuzumab 5
ficlatuzumab 11
firivumab 20
flanvotumab 8
fletikumab 13
foralumab 7
foravirumab 12
fremanezumab 21
fresolimumab 16
fulranumab 18
futuximab 13
galcanezumab 7
ganitumab 18
gantenerumab 4
gemetuzumab 19
gemtuzumab2 18
gemtuzumab 15
gevokizumab 19
girentuximab 15
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 16
ibalizumab 21
ibritumomab 11
icrucumab 5
idarucizumab 17
ifabotuzumab 5
imalumab 14
imgatuzumab 13
inclacumab 9
indatuximab_ravtansin 17
indusatumab 9
inebilizumab 18
intetumumab 5
iodine_girentuximab 26
ipilimumab 0
iratumumab 4
isatuximab 14
itolizumab 16
ixekizumab 21
labetuzumab_govitecan 14
lambrolizumab 19
lampalizumab 16
lanadelumab 16
landogrozumab 9
laprituximab 19
lebrikizumab 23
lendalizumab 20
lenzilumab 11
lifastuzumab_vedotin 20
ligelizumab 18
lilotomab 21
lirilumab 9
lodelcizumab 12
lokivetmab 16
lorvotuzumab_mertansin 11
lucatumumab 25
lumretuzumab 10
lupartumab 7
lutikizumab 13
margetuximab 23
milatuzumab 21
mirvetuximab 20
mirvetuximab_soravtansin 20
modotuximab 22
mogamulizumab 20
monalizumab 16
motavizumab 18
moxetumomab_pasudotox 18
namilumab 11
naratuximab 16
naratuximab_emtansin 16
narnatumab 11
navicixizumab2 19
navicixizumab 20
navivumab 24
necitumumab 6
nemolizumab 16
nesvacumab 10
nivolumab 7
obiltoxaximab 13
obinutuzumab 27
ocaratuzumab 15
ofatumumab 8
olaratumab 12
olokizumab 23
omalizumab 17
onartuzumab 17
ontuxizumab 9
opicinumab 11
orticumab 4
otelixizumab 29
oxelumab 7
ozanezumab 18
pamrevlumab 7
panobacumab 12
parsatuzumab 21
pasotuxizumab 17
pateclizumab 12
patritumab 10
pembrolizumab 19
perakizumab 15
pidilizumab 12
pinatuzumab_vedotin 12
plozalizumab 21
pogalizumab 17
polatuzumab_vedotin 15
ponezumab 22
prezalumab 10
pritoxaximab 17
quilizumab 16
racotumomab 17
radretumab 13
ralpancizumab 18
ramucirumab 10
ranevetmab 16
ranibizumab 17
refanezumab 17
remtolumab 15
rilotumumab 10
rinucumab 13
risankizumab 29
rituximab 13
rivabazumab 11
robatumumab 20
roledumab 16
romosozumab 16
rontalizumab 15
rosmantuzumab 18
rozanolixizumab 14
sacituzumab 13
sacituzumab_govitecan 13
samalizumab 16
sapelizumab 20
sarilumab 11
secukinumab 8
seribantumab 11
setoxaximab 25
sifalimumab 3
siltuximab 16
simtuzumab 18
sirukumab 9
solanezumab 22
solitomab 10
stamulumab 13
suptavumab 15
suvizumab 9
tabalumab 5
tadocizumab 9
tamtuvetmab 22
tanezumab 17
tarextumab 7
tavolixizumab 11
telisotuzumab 18
teplizumab 11
tesidolumab 12
tezepelumab 17
tigatuzumab 13
tildrakizumab 14
timolumab 11
tisotumab 8
tosatoxumab 17
tositumomab 11
tralokinumab 19
trastuzumab 18
tregalizumab 20
trevogrumab 8
ublituximab 13
urelumab 10
ustekinumab 19
utomilumab 19
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 10
vantictumab 11
vanucizumab2 15
vanucizumab 18
varlilumab 12
vatelizumab 15
vedolizumab 11
veltuzumab 4
vesencumab 9
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 24
xentuzumab 14
zatuximab 22
